For the Inventor, By the Inventor

Enter assignee name

High Point, NC, United States of America

High Point Pharmaceuticals, LLC

USPTO Granted Patents = 50

% Expired Patents = 82.0

CIPO Patents = 2

EPO Patents = 24

Forward Citations = 218

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Soren Ebdrup (14 out of 23 patents)

Adnan M M Mjalli (11 out of 74 patents)

Henrik Sune Andersen (10 out of 63 patents)

4. Dharma Rao Polisetti (8 out of 53 patents)

5. Robert Carl Andrews (8 out of 53 patents)

6. Per Sauerberg (7 out of 99 patents)

7. Bapu Reddy Gaddam (7 out of 21 patents)

8. Rolf Hohlweg (7 out of 55 patents)

9. Ingrid Pettersson (6 out of 30 patents)

10. Mohan Rao (6 out of 11 patents)

11. Tan Ren (6 out of 7 patents)

12. Jane Marie Lundbeck (6 out of 24 patents)

13. Gita Camilla Tejlgaard Kampen (6 out of 7 patents)

14. Pavel Pihera (5 out of 11 patents)

15. Miroslav Havranek (5 out of 14 patents)

Core Competencies:

Beta-Secretase Inhibitors

PPAR Activators

TNF-Alpha Modulators

Hydroxysteroid Dehydrogenase

Benzazole Derivatives

Tricyclic Compounds

Histamine H3 Receptor

Imidazole Derivatives

Phenoxy Acetic Acids

Dicarboxylic Acid Derivatives

Piperidine Derivatives

Bissulfonamide Compounds

50 patents: Sort by Forward Citations

1. 8946259 - Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors (2015-02-03),

2. 8927549 - Adamantyl benzamide derivatives (2015-01-06),

3. 8907096 - N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase (2014-12-09),

4. 8853226 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2014-10-07),

5. 8846677 - Medicaments (2014-09-30),

6. 8809540 - N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase (2014-08-19),

7. 8772285 - Benzothiazoles having histamine H3 receptor activity (2014-07-08),

8. 8759535 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2014-06-24),

9. 8598353 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors (2013-12-03),

10. 8563742 - Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use (2013-10-22),

11. 8551993 - Phenoxy acetic acids as PPAR delta activators (2013-10-08),

12. 8513430 - Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators (2013-08-20),

13. 8501739 - Medicaments (2013-08-06),

14. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors (2013-05-28),

15. 8426473 - Phenoxy acetic acids as PPAR delta activators (2013-04-23),

Company Overview

High Point Pharmaceuticals, LLC, based in High Point, North Carolina, specializes in pharmaceutical chemistry with a focus on innovative drug development. The company is engaged in the research and development of novel therapeutic agents, particularly in the areas of beta-secretase inhibitors, PPAR activators, and TNF-alpha modulators. Their expertise extends to hydroxysteroid dehydrogenase, benzazole derivatives, tricyclic compounds, and histamine H3 receptor antagonists, positioning them at the forefront of advancing pharmaceutical solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

50 Patents

#3 in High Point, NC

#170 in North Carolina

#7,009 in US

#14,013 in the World

High Point, NC, United States of America

High Point Pharmaceuticals, LLC

Forward Citations = 218

58 inventors:

Soren Ebdrup (14 out of 23 patents)

Adnan M M Mjalli (11 out of 74 patents)

Henrik Sune Andersen (10 out of 63 patents)

4. Dharma Rao Polisetti (8 out of 53 patents)

5. Robert Carl Andrews (8 out of 53 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: High Point Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/high-point-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…